The purpose of this study is to determine the effective dose of BMS-945429 in subjects with inadequate response to Methotrexate in the treatment of moderate to severe Rheumatoid Arthritis.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01373151?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
